Skip Ribbon Commands
Skip to main content
 
Paediatric Diseases

Introduction

The PDWP aims to support research and education to improve the availability, safety, and efficacy of HSCT and other cellular therapeutics for children and adolescents; to engage and promote active co-operation with all EBMT working parties treating children and adolescents in an effort to meet the total needs of the full spectrum of paediatric HSCT patients; to initiate and perform prospective, collaborative, GCP-conform studies for malignant and non malignant paediatric diseases; to develop further the close collaboration with experts from the Leukaemia/Chemotherapy national frontline studies in order to define the optimal timing of HSCT and incorporate transplant recommendations into the disease specific protocols; to implement the new regulations on paediatric medicines from the EMEA; to offer physicians and nursing staff from small or new centres practical training and fellowships in experienced transplantation units through a European Collaborative Paediatric HSCT network; to further develop established Paediatric Standards within the Accreditation Process through JACIE to guarantee and maintain a high quality of patient care and experience.  

Members 

  

Chairperson
Peter Bader
peter.bader@kgu.de

Vice Chair
Jean-Hugues Dalle
jean-hugues.dalle@rdb.aphp.fr



Secretary
Andre Willasch
AndreManfred.Willasch@kgu.de

 

Studies coordinated by the PDWP

Click HERE to view the Current Research list 

How to get involved?

Please contact the Chairperson or the Secretary.

 

 News

 
17/05/2017
The EBMT implements Elsevier’s MACRO platform to upgrade patient registry.... Read more >>
05/10/2016
​EBMT TV returns to 2017 Annual Meeting... Read more >>
26/09/2016
​The EBMT has contributed to the Innovative Medicines Intiative... Read more >>
10/05/2016
​More than 60 EBMT centres have already started entering their related donor data. We want to invite... Read more >>
 

 Events

 
Bookmark and Share